Compare ACU & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACU | LUCD |
|---|---|---|
| Founded | 1867 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.0M | 132.4M |
| IPO Year | N/A | 2021 |
| Metric | ACU | LUCD |
|---|---|---|
| Price | $41.44 | $1.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $3.94 |
| AVG Volume (30 Days) | 9.1K | ★ 654.8K |
| Earning Date | 02-27-2026 | 11-12-2025 |
| Dividend Yield | ★ 1.51% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.45 | N/A |
| Revenue | ★ $194,960,991.00 | $4,399,000.00 |
| Revenue This Year | $2.19 | $11.18 |
| Revenue Next Year | $4.55 | $147.43 |
| P/E Ratio | $17.26 | ★ N/A |
| Revenue Growth | 2.35 | ★ 5.01 |
| 52 Week Low | $34.35 | $0.80 |
| 52 Week High | $45.25 | $1.80 |
| Indicator | ACU | LUCD |
|---|---|---|
| Relative Strength Index (RSI) | 64.21 | 62.74 |
| Support Level | $38.83 | $1.12 |
| Resistance Level | $43.13 | $1.15 |
| Average True Range (ATR) | 1.10 | 0.04 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 74.89 | 87.85 |
Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.